Rebel Curd is a speaker at Global Transfer Pricing: Key Strategies and New Opportunities for Pharma/Biotech Companies. Rebel moderated a panel entitled, “Global Audit Planning and Defense”.
For more information on this event, click here.
Measuring and mitigating harm from discriminatory taxes
In the article the authors examine the April 2 Executive Order signed by President Trump highlighting US trading partners’ nontariff barriers, such as...